LONDON, March 5, 2026 /PRNewswire/ — Tetragon has published its 2025 Annual Report. Please click below to access the report.
Tetragon Financial Group Limited 2025 Annual Report
Or access it via the following URL: https://www.tetragoninv.com/shareholders/reports-and-presentations/
As a reminder, Tetragon will host a conference call for investors on Friday, 6 March 2026 at 15:00 GMT / 10:00 EST to discuss its annual report and to provide a company update.
During the call, Tetragon’s investment manager will also seek to address questions raised by investors, including questions e-mailed to ir@tetragoninv.com.
Getting access to the call and Q&A:
The call will be accompanied by a live presentation which can be viewed online by registering at the link below. In addition, questions can be submitted online while watching the presentation. We would encourage you to log in 15 minutes prior to the start of the call.
Webcast – please use the following link to register and access the live event webcast:
https://onlinexperiences.com/Launch/QReg/ShowUUID=20921406-30B9-4C4F-A213-EF8C0229731C.
Audio conference – please use the following link to register for your personal audio conference call details if you cannot join the webcast: https://emportal.ink/4tgNFcH.
Presentation replay – a replay of the call will be available for 30 days through the link provided above or by visiting www.tetragoninv.com/shareholders/calendar-events/ where a recording will posted.
About Tetragon:
Tetragon Financial Group is a Guernsey closed-ended investment company. Its non-voting shares are listed on Euronext in Amsterdam, a regulated market of Euronext Amsterdam N.V., and also traded on the Specialist Fund Segment of the Main Market of the London Stock Exchange. Our investment manager is Tetragon Financial Management LP. Find out more at www.tetragoninv.com/shareholders.
Tetragon’s non-voting shares are subject to restrictions on ownership by U.S. persons and are not intended for European retail investors. Please see: www.tetragoninv.com/shareholders/additional-info/.
Tetragon Investor Relations:
Yuko Thomas
ir@tetragoninv.com
Press Inquiries:
Prosek Partners
pro-tetragon@prosek.com
U.K. +44 20 3890 9193
U.S. +1 212 279 3115
This release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation (2014/596/EU), or EU MAR, and of the UK version of EU MAR as it forms part of UK law by virtue of the European Union (Withdrawal) Act (as amended).
This release does not contain or constitute an offer to sell or a solicitation of an offer to purchase securities in the United States or any other jurisdiction. The securities of Tetragon have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States or to U.S. persons unless they are registered under applicable law or exempt from registration. Tetragon does not intend to register any portion of its securities in the United States or to conduct a public offer of securities in the United States. In addition, Tetragon has not been and will not be registered under the U.S. Investment Company Act of 1940, as amended, and investors will not be entitled to the benefits of such Act. Tetragon is registered in the public register of the Netherlands Authority for the Financial Markets (Autoriteit Financiële Markten) under Section 1:107 of the Dutch Financial Markets Supervision Act as an alternative investment fund from a designated state.
View original content:https://www.prnewswire.co.uk/news-releases/tetragon-financial-group-limited-2025-annual-report-302705670.html
The content and accuracy of news releases published on this site and/or distributed by PR Newswire or its partners are the sole responsibility of the originating company or organisation. Whilst every effort is made to ensure the accuracy of our services, such releases are not actively monitored or reviewed by PR Newswire or its partners and under no circumstances shall PR Newswire or its partners be liable for any loss or damage resulting from the use of such information. All information should be checked prior to publication.
